An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline reuptake inhibitor, in patients with DSM-III-R major depressive disorder
Berk, M., du Plessis, A. D., Birkett, M., Richardt, D. and Lilly Duloxetine Depression Study Group 1997, An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline reuptake inhibitor, in patients with DSM-III-R major depressive disorder, International Clinical Psychopharmacology, vol. 12, no. 3, pp. 137-140.
Attached Files
Name
Description
MIMEType
Size
Downloads
Title
An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline reuptake inhibitor, in patients with DSM-III-R major depressive disorder
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.